Release Date: 17/11/10 16:52 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 141.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%